Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 22;3(4):378-389.
doi: 10.1002/ags3.12266. eCollection 2019 Jul.

Essential updates to the surgical treatment of biliary tract cancer

Satoshi Matsukuma  1 , Yukio Tokumitsu  1 , Yoshitaro Shindo  1 , Hiroto Matsui  1 , Hiroaki Nagano  1
Affiliations

Essential updates to the surgical treatment of biliary tract cancer

Satoshi Matsukuma et al. Ann Gastroenterol Surg. .

Abstract

Biliary tract cancer, which includes intrahepatic cholangiocarcinoma, extrahepatic bile duct cancer, gallbladder cancer, and ampullary cancer, is an intractable disease with a dismal prognosis. Prognosis is particularly poor in cases involving vessels or lymph nodes. Hepatobiliary pancreatic surgeons worldwide have consistently focused on improving surgical treatment, perioperative management, and chemotherapy to improve the outcomes of these diseases. There has been significant progress even in the last 2 years (2017 and 2018), such as promising findings reported by studies on the optimal extent of surgical treatment and multi-institutional randomized controlled trials on adjuvant chemotherapy. We overview the current trends and advancements made in surgical treatment in 2017 and 2018.

Keywords: adjuvant therapy; biliary tract cancer; cholangiocarcinoma; gallbladder cancer; surgical treatment.

PubMed Disclaimer

References

    1. Aoki T, Sakamoto Y, Kohno Y, Akamatsu N, Kaneko J, Sugawara Y, et al. Hepatopancreaticoduodenectomy for biliary cancer: strategies for near‐zero operative mortality and acceptable long‐term outcome. Ann Surg. 2018;267(2):332–7. - PubMed
    1. Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical resection for bismuth type IV perihilar cholangiocarcinoma. Br J Surg. 2018;105(7):829–38. - PubMed
    1. Bird N, Elmasry M, Jones R, Elniel M, Kelly M, Palmer D, et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma. Br J Surg. 2017;104(4):418–25. - PubMed
    1. Zhang XF, Chakedis J, Bagante F, Chen Q, Beal EW, Lv Y, et al. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. Br J Surg. 2018;105(7):857–66. - PubMed
    1. Kasumova GG, Tabatabaie O, Najarian RM, Callery MP, Ng SC, Bullock AJ, et al. Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy. Ann Surg. 2017;266(4):625–31. - PubMed